APPLICATIONS PUBLISHED 18 JUNE 2003
Published: 1-Dec-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Compsn of vitamin C and/or vitamin A
Industria E Comercio de Cosmeticos Natura 1318784*
Pulmonary delivery in treating diseases of the central nervous system
Advanced Inhalation Research 1318785*
Implantable drug delivery patch
Durect Corp 1318786*
Pharmaceutical suspension compsns lacking a polymeric suspending agent
Alcon 1318787*
Solid dose nanoparticulate compsns
Elan Pharmaceuticals 1318788*
Method for granulation of active substances by low pressure extrusion to obtain directly compressible granules
Rhodia Chemie 1318789*
Pharmaceutical compsns for rectal and vaginal administration
CIMA Labs 1318790*
Pharmaceutical semi-solid compsn of isotretinoin
Galephar 1318791*
Sustained release compsn containing clarithromycin
Galephar 1318792*
Method for reducing toxicity of combined chemotherapies
Bristol-Myers Squibb 1318794*
Anthelmintics for preventing parasitic infections in humans and animals
Bayer 1318795*
Polynucleotide intercalation interceptors and inhibitors
Lyles, Mark 1318796*
Volatile anaesthetic with xenon
Messer Griesheim 1318797*
Water-soluble prodrugs of propofol for treatment of migraine
Vyrex 1318798*
Stable dosage forms containing ubiquinones
Abbott 1318799*
1-amino-alkylcyclohexanes as tryptanocidal agents
Merz 1318800*
Topical analgesic compsns containing aliphatic polyamines and methods of using same
Dermal Therapy (Barbados) 1318801*
Substituted hydrazine derivatives
Gliatech 1318802*
Fatty acid synthase inhibitors
SmithKline Beecham 1318803*
Iron compsns
Vitra Pharmaceuticals 1318804*
Pharmaceutical compsn containing citalopram
H Lundbeck 1318805*
Fatty acid synthase inhibitors
SmithKline Beecham 1318806*
Photosensitising ointment
CermaOptec 1318807*
Method of treating aquatic animals with an antimicrobial agent and a chelating agent
The University of Georgia Research Foundation 1318808*
Micronised torsemide
Teva Pharmaceutical Industries 1318809*
Manzamines for treatment of drug resistant infection
University of Mississippi, National Centre for Natural Products Research 1318810*
Cyclopentyl modulators of chemokine receptor activity
Merck 1318811*
Methods for delaying recurrence of herpes virus symptoms
3M Innovative Properties 1318812*
Stable pergolide mesylate and process for making same
Teva Pharmaceutical Industries 1318813*
Triazole compounds useful as protein kinase inhibitors
Vertex Pharmaceuticals 1318814*
Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
Valletta, Giampiero 1318815*
Corticosteroid formulation comprising less than 2.5mg prednisolone for once daily administration
Arakis 1318816*
Use of arginine in the preparation of a medicament for the prevention and treatment of the side-effects associated with intravenous administration of pharmaceuticals
Pharmacia Italia 1318817*
Diphosphonate solutions
Handreck, Gregory 1318818*
Treatment of trauma, and other indications
Phairson Medical 1318819*
Xenon as medicament
Messer Griesheim 1318820*
Fluid for haemofiltration
Hollander, Adrianus Atonius Marcus Johannes 1318821*
Cell implantation therapy for neurological diseases or disorders
The McLean Hospital Corp 1318822*
Immunomodulatory preparation
Pharmalink International 1318823*
Extracts from the fungus Guignardia sp., their uses in pharmaceutical compsns, new isolate compound from the extract of the fungus Guignardia sp. and its use in pharmaceutical compsns
Fundacao Oswaldo Cruz (Fiocruz) 1318824*
Plant extract
Vitaplant 1318825*
Use of Buchu extracts for hypertension
Stander, Michael 1318826*
Polymer-modified synthetic proteins
Gryphon Therapeutics 1318827*
Orally administered peptides to ameliorate atherosclerosis
The Regents of the University of California 1318828*
Angiogenic agents and their uses
Centre National de la Recherche Scientifique 1318829*
Notch receptor agonists and uses
Genentech 1318830*
The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism
Universitair Medisch Centrum Utrecht; Rikjsuniversiteit Utrecht 1318831*
The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases
Universitair Medisch Centrum Utrecht; Rikjsuniversiteit Utrecht 1318832*
Compsns and methods for cell dedifferentiation and tissue regeneration
The University of Utah Research Foundation 1318833*
Compsns comprising mixtures of human cytokines and methods for producing the same
Genetrol Biotherapeutics 1318834*
Use of imidazoquinolinamines as adjuvants in DNA vaccination
Glaxo Group 1318835*
Treatment of hyperproliferative diseases
Molecular Skincare 1318836*
Method of treating estrogen receptor positive carcinoma
Wyeth 1318837*
